Dr Julie Milstein: A practical guide to vaccine pre-qualification in China 16 July 2012 / By Marcia Ardila / Emerging Markets / 0 comments
The need for new approaches to global #vaccine pricing 8 June 2012 / By Marcia Ardila / Partnering and Corporate strategy / 0 comments
Hepatitis C #Vaccines: Challenges and Future Perspectives 7 June 2012 / By Marcia Ardila / R&D, Therapeutic Vaccines / 0 comments
#Vaccine pricing and adaptation in developing countries 7 June 2012 / By Marcia Ardila / Uncategorized / 0 comments
HEPLISAV™ efficacy in the Hep B #vaccine field 6 June 2012 / By Marcia Ardila / R&D, Therapeutic Vaccines / 0 comments
Pandemic and Prepandemic influenza #vaccine development in the Russian Federation 5 June 2012 / By Marcia Ardila / Flu, R&D / 0 comments
Maintaining the link between seasonal influenza #vaccine production and pandemic readiness 4 June 2012 / By Marcia Ardila / Flu / 0 comments
Download: Discover the 6 key growth areas in the #vaccine industry 29 May 2012 / By Marcia Ardila / Events / 0 comments
Hepatitis B – what’s new on the HBV #vaccine watch? 2 May 2012 / By Marcia Ardila / Prophylactic Vaccines / 0 comments
#wvcusa Immunome-Derived vaccines – the next wave of vaccine design 2 May 2012 / By Marcia Ardila / R&D / 0 comments
